Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Rethinking Psoriasis: Why It’s Time to Elevate Treatment Expectations and Outlooks 

Program Information

Program Information

ReachMD Healthcare Image

The impact of psoriasis on affected individuals is not solely determined by the extent of skin involvement. What’s our new way of thinking when it comes to evaluating psoriasis severity and patients’ eligibility for systemic therapies?

Take Post-Survey

If you’ve already completed the activity.

  • Sponsored by

  • Overview

    Since we’re starting to reevaluate how we think about psoriasis severity and which patients are eligible for systemic therapies, Dr. April Armstrong leading dermatologist from University of Southern California is here to walk us through how traditional classifications of disease severity may not be sufficient to reflect the full impact of psoriasis on patients.

    VERSION 1.0 | APRIL 2021 | ABBV-US-00440-MC

Schedule19 Oct 2021